Wednesday, July 8, 2026

pharma · Hypertriglyceridemia · Type 2 Diabetes Mellitus · IONS

IONIS PHARMACEUTICALS

IONIS PHARMACEUTICALS is a pharma organization headquartered in Carlsbad, USA. It trades on NYSE under ticker IONS. Primary therapeutic focus areas include Hypertriglyceridemia, Type 2 Diabetes Mellitus, Familial Chylomi

2855 Gazelle Ct, Carlsbad, CA 92010, US HQ
1989 Founded
1,493 Employees
Public company Type
IONS · NYSE Ticker
Company details
Status
Public
HQ
2855 Gazelle Ct, Carlsbad, CA 92010, US
Founded
1989
Employees
1,493
Programs
128
Drugs
48
Patents
222
Clinical program

ISIS CRP Rx or Placebo

Phase 2 · small molecule · Rheumatoid Arthritis

ISIS CRP Rx or Placebo for Rheumatoid Arthritis is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

← All IONIS PHARMACEUTICALS INC projects Phase 2 small molecule completed

Internal code ISIS 329993-CS3

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
IONIS PHARMACEUTICALS INC
Phase
Phase 2
Modality
small_molecule
Indication
Rheumatoid Arthritis
Status
completed
Trials
1

Clinical trials